A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical ...

From molecular developability to functional activity, integrated characterization strategies help inform lead selection and ...

Lonza buys five US CDMO sites from Merck KGaA, adding ADC conjugation, viral vector, and LNP manufacturing as CDMO ...

Across SLAS Europe 2026, the focus was on AI and automation, but the tone was notably pragmatic. While AI featured heavily across keynote sessions and vendor demonstrations, the emphasis was less on ...

Reversing age-related changes in liver cells reduced circulating amyloid beta and cholesterol in rats, revealing a potential ...

GLP-1 receptor agonists have become the defining drug class of the decade. Initially developed to treat diabetes, they have exploded into the mainstream as powerful weight-loss agents, reshaping not ...

GLP-1 manufacturing challenges have become the binding constraint on one of the most successful drug classes in history. Demand for semaglutide and tirzepatide outran the industry’s ability to make ...

Sævik measures corticosteroid levels in people with Addison’s disease to challenge the pervasive idea that these patients lose all adrenal cortex function as their disease progresses. Åse Bjorvatn ...

Researchers ​are beginning to uncover differences in brain metabolism and cognitive performance among people with PMOS, but ...

Using bioinformatics and machine learning, scientists probe the depths of fungal genomes to find new compounds for undruggable cancers and infections. Fungi have been at war for millennia. Over the ...

Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic ...

MONTPELLIER, France—The French biotech company Ciloa recently scored a first for it and its exosome work when it announced recently that one of its projects had been chosen for the Sanofi iTech Awards ...